Journal of Surgical Research
Volume 152, Issue 2 , Pages 238-248 , April 2009

The Effects of Riluzole on Neurological, Brain Biochemical, and Histological Changes in Early and Late Term of Sepsis in Rats

  • Hale Z. Toklu, Ph.D.

      Affiliations

    • Department of Pharmacology, Marmara University School of Pharmacy, Istanbul, Turkey
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Pharmacology, Marmara University School of Pharmacy, Tibbiye Cad. no: 49 Haydarpasa (34668), Istanbul, Turkey
    • ,
  • Meral Keyer Uysal, Ph.D.

      Affiliations

    • Department of Pharmacology, Marmara University School of Pharmacy, Istanbul, Turkey
    • ,
  • Levent Kabasakal, Ph.D.

      Affiliations

    • Department of Pharmacology, Marmara University School of Pharmacy, Istanbul, Turkey
    • ,
  • Serap Sirvanci, M.D., Ph.D.

      Affiliations

    • Department of Histology, Embryology, Marmara University School of Medicine, Istanbul, Turkey
    • ,
  • Feriha Ercan, Ph.D.

      Affiliations

    • Department of Histology, Embryology, Marmara University School of Medicine, Istanbul, Turkey
    • ,
  • Mehmet Kaya, Ph.D.

      Affiliations

    • Department of Physiology, Istanbul University School of Medicine, Istanbul, Turkey

Received 23 November 2007

References 

  1. Weigand MA, Horner C, Bardenheuer HJ, et al. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol. 2004;18:455
  2. Neviere RR, Ceepinskas G, Madorin WS, et al. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: Role of myocytes. Am J Physiol. 1999;277:H885
  3. Green R, Scott LK, Minagar A, et al. Sepsis associated encephalopathy (SAE): A review. Front Biosci. 2004;9:1637
  4. Papadopoulos MC, Davies DC, Moss RF, et al. Pathophysiology of septic encephalopathy: A review. Crit Care Med. 2000;28:3019
  5. Hendriks JJ, Teunissen CE, de Vries HE, et al. Macrophages and neurodegeneration. Brain Res Rev. 2005;48:185
  6. De Vries HE, Kuiper J, De Boer AG, et al. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev,. 1997;49:143
  7. Volk T, Kox WJ. Endothelium function in sepsis. Inflam Res. 2000;49:185
  8. Peters K, Unger RE, Brunner J, et al. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60:49
  9. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol. 2003;27:325
  10. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001;40:959
  11. Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47:S233
  12. Wahl F, Renou E, Mary V, et al. Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury. Brain Res. 1997;756:247
  13. Wahl F, Stutzmann JM. Neuroprotective effects of riluzole in neurotrauma models: A review. Acta Neurochir. 1999;73(Suppl):103
  14. Bryson HM, Fulton B, Benfield P, et al. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs. 1996;52:549
  15. Mohammadi B, Krampfl K, Moschref H, et al. Interaction of the neuroprotective drug riluzole with GABA(A) and glycine receptor channels. Eur J Pharmacol. 2001;415:135
  16. He Y, Benz A, Fur T, et al. Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function. Neuropharmacology. 2002;42:199
  17. Urenjak J, Obrenovitch TP. Pharmacological modulation of voltage-gated Na+ channels: A rational and effective strategy against ischemic brain damage. Pharmacol Rev. 1996;48:21
  18. Urenjak J, Obrenovitch TP. Pharmacological modulation of voltage-gated Na+ channels by riluzole: An alternative to antiexitotoxic actions. Rev Contemp Pharmacother. 1997;8:237
  19. Koh JY, Kim DK, Hwang JY, et al. Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons. J Neurochem. 1999;72:716
  20. Mu X, Azbill RD, Springer JE. Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res. 2000;870:66
  21. Storch A, Burkhardt K, Ludolph AC, et al. Protective effects of riluzole on dopamine neurons: Involvement of oxidative stress and cellular energy metabolism. J Neurochem. 2000;75:2259
  22. Sener G, Toklu H, Ercan F, et al. Protective effect of β-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol. 2005;5:1387
  23. Obrenovitch TP, Urenjak J. Actions of riluzole in animal models of CNS ischemia and trauma. Rev Contemp Pharmacother. 1997;8:227
  24. Kaya M, Palanduz A, Kalayci R, et al. Effects of lipopolysaccharide on the radiation-induced changes in the blood-brain barrier and the astrocytes. Brain Res. 2004;1019:105
  25. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurological examination. Stroke. 1986;17:472
  26. Ogan A. Batın içi sepsiste metilprednizolonun kan-beyin bariyeri geçirgenlik artısşı ve nörolojik degğerlendirme üzerine etkisi (Thesis, Istanbul University School of Medicine Department of Anestesiology and Reanimation). Adviser: Prof. Dr. Figen Esen. Thesis no: 124366 YOK Thesis Center; 2003;
  27. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302
  28. Beutler E. Glutathione. In:  Beutler E editors. Red blood cell metabolism—A manual of biochemical methods. New York: Grune and Stratton; 1975;p. 112–114
  29. Durmaz R, Ertilav K, Akyuz F, et al. Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury. J Neurol Sci. 2003;215:87
  30. Singh J, Gupta MC. Effect of aspartate and glutamate on nociception, catalepsy, and core temperature in rats. Ind J Physiol Pharmacol. 1997;41:123
  31. Mariak Z, Lyson T, Rudzinski W. Hypothermia as a neuroprotective agent. Pol J Neurol Neurosurg. 2004;38:51
  32. Riedel W, Lang U, Oetjen U, et al. Inhibition of oxygen radical formation by methylene blue, aspirin, or α-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol Cell Biochem. 2003;247:83
  33. Hund E. Neurological complications of sepsis: Critical illness polyneuropathy and myopathy. J Neurol. 2001;248:929
  34. Bogdanski R, Blobner M, Becker I, et al. Cerebral histopathology following portal venous infusion of bacteria in a chronic porcine model. Anesthesiology. 2000;93:793
  35. Bogdanski R, Blobner M, Werner C. Critical illness polyneuropathy and myopathy: Do they persist for lifetime?. Crit Care Med. 2003;31:1279
  36. McIntosh TK, Smith DH, Voddi M, et al. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. J Neurotrauma. 1996;13:767
  37. Kanthasamy AG, Yun RJ, Nguyen B, et al. Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder. J Pharmacol Exp Ther. 1999;288:1340
  38. Kogo J, Takeba Y, Kumai T, et al. Involvement of TNF-α in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Res. 2006;1122:201
  39. Figiel I, Dzwonek K. TNF-α and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res. 2007;1131:17
  40. Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489
  41. Malmezat T, Breuille D, Capitan P, et al. Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr. 2000;130:1239
  42. Villa P, Saccani A, Sica A, et al. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis. 2002;185:1115
  43. Noh KM, Hwang JY, Shin HC, et al. A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C. Neurobiol Dis. 2000;7:375
  44. Papadopoulos MC, Lamb FJ, Moss RF, et al. Fecal peritonitis causes edema and neuronal injury in pig cerebral cortex. Clin Sci (London). 1999;96:461
  45. Kaptanoglu E, Okutan O, Akbiyik F, et al. Correlation of injury severity and tissue Evans blue content, lipid peroxidation, and clinical evaluation in acute spinal cord injury in rats. J Clin Neurosci. 2004;11:879
  46. Tongren JE, Yang C, Collins WE, et al. Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (Rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg. 2000;62:530
  47. Barichello T, Fortunato JJ, Vitali AM, et al. Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med. 2006;34:886
  48. Mizuta I, Ohta M, Ohta K, et al. Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett. 2001;310:117
  49. Janis LS, Stein DG. Intraseptal injections of NGF attenuates edema formation following septal lesions in the rat. Neurosci Lett. 1996;214:21
  50. Kempski O. Cerebral edema. Semin Nephrol. 2001;21:303
  51. Unterberg AW, Stover J, Kress B, et al. Edema and brain trauma. Neuroscience. 2004;129:1021
  52. Obrenovitch TP. Neuroprotective strategies: Voltage-gated Na+ channel down-modulation versus presynaptic glutamate release inhibition. Rev Neurosci. 1998;9:203
  53. Zona C, Siniscalchi A, Mercuri NB, et al. Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience. 1998;85:931
  54. Mantz J, Chéramy A, Thierry AM, et al. Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission. Anesthesiology. 1992;76:844

PII: S0022-4804(08)00197-2

doi: 10.1016/j.jss.2008.03.013

Journal of Surgical Research
Volume 152, Issue 2 , Pages 238-248 , April 2009

Article Tools

* Image Usage & Resolution